This inventor holds 1 USPTO granted patent. Top assignee: Lg Life Sciences, Limited. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Joon Kim: Innovator in Protein Drug Delivery Systems
Introduction
Joon Kim is a notable inventor based in Taejon, South Korea. He has made significant contributions to the field of drug delivery systems, particularly through his innovative work on lipophilic-coated microparticles. His research focuses on enhancing the efficacy and stability of protein and peptide drugs.
Latest Patents
One of Joon Kim's key patents is titled "Lipophilic-coated microparticle containing a protein drug and formulation comprising same." This patent describes a solid lipophilic microparticle with an average particle size ranging from 0.1 to 200 µm. The microparticle comprises a lipophilic substance, hyaluronic acid or an inorganic salt thereof, and an active ingredient selected from the group consisting of a protein or peptide drug. This formulation retains the full activity of the active ingredient and, when formulated as an oil dispersion or oil-in-water emulsion, releases the active ingredient in a controlled manner over an extended period in an in vivo environment.
Career Highlights
Joon Kim is currently associated with LG Life Sciences, Limited, where he continues to advance his research in drug delivery technologies. His work has garnered attention for its potential to improve therapeutic outcomes for patients requiring protein-based medications.
Collaborations
Joon Kim collaborates with several talented individuals in his field, including Myung-Jin Kim and Sun-jin Kim. Their combined expertise contributes to the innovative projects at LG Life Sciences, Limited.
Conclusion
Joon Kim's contributions to the field of drug delivery systems exemplify the importance of innovation in enhancing the effectiveness of medical treatments. His work on lipophilic-coated microparticles represents a significant advancement in the formulation of protein drugs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile